DK1238086T3 - Vaccine til forögelse af immunreaktioner på herpes simplex virus - Google Patents

Vaccine til forögelse af immunreaktioner på herpes simplex virus

Info

Publication number
DK1238086T3
DK1238086T3 DK00983967T DK00983967T DK1238086T3 DK 1238086 T3 DK1238086 T3 DK 1238086T3 DK 00983967 T DK00983967 T DK 00983967T DK 00983967 T DK00983967 T DK 00983967T DK 1238086 T3 DK1238086 T3 DK 1238086T3
Authority
DK
Denmark
Prior art keywords
type
hsv
nucleic acid
protein
mammal
Prior art date
Application number
DK00983967T
Other languages
Danish (da)
English (en)
Inventor
Eric M Mishkin
Robert J Natuk
Michael W Pride
Maninder K Sidhu
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of DK1238086T3 publication Critical patent/DK1238086T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A61K2039/55527—Interleukins
    • A61K2039/55538—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK00983967T 1999-12-17 2000-12-07 Vaccine til forögelse af immunreaktioner på herpes simplex virus DK1238086T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17231399P 1999-12-17 1999-12-17

Publications (1)

Publication Number Publication Date
DK1238086T3 true DK1238086T3 (da) 2006-06-26

Family

ID=22627181

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00983967T DK1238086T3 (da) 1999-12-17 2000-12-07 Vaccine til forögelse af immunreaktioner på herpes simplex virus

Country Status (16)

Country Link
EP (1) EP1238086B1 (pt)
JP (1) JP2003517042A (pt)
KR (1) KR100773390B1 (pt)
CN (1) CN1222619C (pt)
AT (1) ATE319833T1 (pt)
AU (1) AU783730B2 (pt)
BR (1) BR0016419A (pt)
CA (1) CA2406678A1 (pt)
CY (1) CY1105604T1 (pt)
DE (1) DE60026588T2 (pt)
DK (1) DK1238086T3 (pt)
ES (1) ES2258987T3 (pt)
IL (1) IL149810A0 (pt)
MX (1) MXPA02005867A (pt)
PT (1) PT1238086E (pt)
WO (1) WO2001044477A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050086427A (ko) * 2002-11-07 2005-08-30 시너지 아메리카 인코포레이티드 폐렴균의 감염 치료 또는 예방용 조성물 및 방법
CN102458463B (zh) * 2009-05-22 2017-01-18 健诺西生物科学公司 针对ⅱ型单纯疱疹病毒的疫苗：诱发免疫应答的组合物和方法
KR101008582B1 (ko) * 2010-09-20 2011-01-17 (주)칠칠공사 달비계용 2중 안전 샤클조립체
EP2643014A4 (en) 2010-11-24 2015-11-11 Genocea Biosciences Inc HERPES SIMPLEX TYPE 2 VIRUS VACCINES: COMPOSITIONS AND METHODS FOR STIMULATING AN IMMUNE RESPONSE
EP2782597B1 (en) * 2011-11-23 2022-04-13 Genocea Biosciences, Inc. Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
WO2014107731A1 (en) 2013-01-07 2014-07-10 Biomedical Research Models, Inc. Therapeutic vaccines for treating herpes simplex virus type 2 infections
US10918712B2 (en) 2014-03-03 2021-02-16 Albert Einstein College Of Medicine Passive transfer of immunity using recombinant herpes simplex virus 2 (HSV-2) vaccine vectors
EP3943106A1 (en) 2014-03-03 2022-01-26 Albert Einstein College of Medicine Recombinant herpes simplex virus 2 (hsv-2) vaccine vectors
CN104721839A (zh) * 2015-03-17 2015-06-24 浙江省医学科学院 一种预防单纯疱疹病毒ii型的疫苗
CN104830781A (zh) * 2015-05-05 2015-08-12 杨光华 基于hsv-2抗原的dc细胞、靶向性免疫细胞群及其制备方法和用途
EP3519427A4 (en) 2016-09-28 2020-03-11 Genocea Biosciences Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF HERPES
CN111051333B (zh) * 2017-08-30 2024-04-05 Km生物医薬股份公司 修饰型HSV gD蛋白及包含其的疫苗

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2226338T3 (es) * 1998-02-12 2005-03-16 Wyeth Holdings Corporation Vacuna que comprenden interleucina 12 y antigeno del virus del herpes simple.

Also Published As

Publication number Publication date
ES2258987T3 (es) 2006-09-16
EP1238086A1 (en) 2002-09-11
ATE319833T1 (de) 2006-03-15
MXPA02005867A (es) 2002-10-23
CA2406678A1 (en) 2001-06-21
AU783730B2 (en) 2005-12-01
KR100773390B1 (ko) 2007-11-09
CN1222619C (zh) 2005-10-12
EP1238086B1 (en) 2006-03-08
DE60026588T2 (de) 2007-01-18
WO2001044477A1 (en) 2001-06-21
BR0016419A (pt) 2002-08-20
CN1434864A (zh) 2003-08-06
AU2065101A (en) 2001-06-25
PT1238086E (pt) 2006-07-31
CY1105604T1 (el) 2010-07-28
JP2003517042A (ja) 2003-05-20
IL149810A0 (en) 2002-11-10
DE60026588D1 (de) 2006-05-04
KR20020073348A (ko) 2002-09-23

Similar Documents

Publication Publication Date Title
CY1105604T1 (el) Μεθοδος ενισχυσης ανοσων απαντησεων στο εμβολιο κατα του ιου του απλου ερπητα
DK0587780T4 (da) Smitstof, som forårsager Mystery Swine Disease,vaccinepræparater og diagnostiske sæt
NZ503763A (en) Antigenic compositions and vaccines comprising a high molecular weight (HMW) protein of Clamydia for therapeutic and prophylactic use
DK0851927T3 (da) Forbindelser til immunterapi og diagnosticering af tuberkulose
CA2660355A1 (en) Polynucleotide vaccine formulation against pathologies of the horse
BRPI0408779A (pt) uso de composições, composição imunogênica e kit
IS4518A (is) Nýtt lyfjaform fyrir bóluefni
DE60125797D1 (de) Impfstoffzusammesetzung
WO1998053075A3 (en) Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
BR0014138A (pt) Uso de um vetor adenoviral deficiente em replicação, e, métodos para reforçar, e para induzir resposta imune de célula cd8+ t a um antìgeno em um indivìduo
WO2002024739A3 (en) Spas-1 cancer antigen
DK0587735T3 (da) T-cellereceptorpeptider som terapeutiske midler til immunrelateret sygdom
DK0806966T3 (da) Katoniske copolymerer af vinylamin og vinylalkohol til administration af oligonukleotider
BR0207528A (pt) Anticorpo, composição farmacêutica, e, usos de uma quantidade efetiva de um agente, de uma quantidade terapeuticamente efetiva de um anticorpo para il-22, de uma quantidade imunogênica do antìgeno e uma quantidade aumentadora de imunogenicidade de il-22 em combinação, de uma quantidade efetiva do anticorpo ou fragmento do mesmo e de uma quantidade suficiente de anticorpo ou fragmento ligado a antìgeno do mesmo
WO1996018646A3 (en) Heat shock protein peptides and methods for modulating autoimmune central nervous system disease
EA200100395A1 (ru) Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием
BR0115646A (pt) Composição, dispositivo de liberação de partìculas, uso de uma composição, e, método para intensificar uma resposta imune contra um antìgeno de interesse em um paciente
AU8467201A (en) Compositions for and methods of using herpes simplex virus glycoprotein d to suppress immune responses
WO1999053960A3 (en) Enhancing immune responses to genetic immunization by using a chemokine
BR0013574A (pt) Antìgeno vacina de moraxella
ATE374622T1 (de) Genetische impstoffe mit adjuvans
BR9905780A (pt) Antìgenos vacinais de leptospira para prevenção da laptospirose
DK0524421T3 (da) Humant herpesvirus type 6 protein p 100, de tilsvarende DNA-sekvenser, deres fremstilling og anvendelse
BR0213554A (pt) Timosina para aumento da imunização genética
BR0016740A (pt) Antìgenos de esporozoìto de cryptosporidium